BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32079621)

  • 21. Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First-Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials.
    Younger E; Litière S; Le Cesne A; Mir O; Gelderblom H; Italiano A; Marreaud S; Jones RL; Gronchi A; van der Graaf WTA
    Oncologist; 2018 Oct; 23(10):1250-1259. PubMed ID: 29650688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study.
    Jansen-Landheer ML; Krijnen P; Oostindiër MJ; Kloosterman-Boele WM; Noordijk EM; Nooij MA; Steup WH; Taminiau AH; Vree R; Hogendoorn PC; Tollenaar RA; Gelderblom H
    Eur J Surg Oncol; 2009 Dec; 35(12):1326-32. PubMed ID: 19525085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of factors influencing treatment results in children with soft tissue head and neck sarcomas - in the material of the Department of Paediatrics, Haematology, Oncology and Endocrinology, Medical University of Gdansk].
    Bień E; Stachowicz-Stencel T; Adamkiewicz-Drozyńska E; Połczyńska K; Sierota D; Stefanowicz J; Szołkiewicz A; Hennig M; Krawczyk M; Balcerska A
    Med Wieku Rozwoj; 2008; 12(4 Pt 2):1074-81. PubMed ID: 19531829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first-line chemotherapy: An exploratory, retrospective analysis of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG).
    Lindner LH; Litière S; Sleijfer S; Benson C; Italiano A; Kasper B; Messiou C; Gelderblom H; Wardelmann E; Le Cesne A; Blay JY; Marreaud S; Hindi N; Desar IME; Gronchi A; van der Graaf WTA
    Int J Cancer; 2018 Jun; 142(12):2610-2620. PubMed ID: 29383713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome of chemotherapy in advanced synovial sarcoma patients: Review of 15 clinical trials from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group; setting a new landmark for studies in this entity.
    Vlenterie M; Litière S; Rizzo E; Marréaud S; Judson I; Gelderblom H; Le Cesne A; Wardelmann E; Messiou C; Gronchi A; van der Graaf WT
    Eur J Cancer; 2016 May; 58():62-72. PubMed ID: 26968015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective comparison of various radiological response criteria and pathological response to preoperative chemotherapy and survival in operable high-grade soft tissue sarcomas in the Japan Clinical Oncology Group study JCOG0304.
    Tanaka K; Ogawa G; Mizusawa J; Naka N; Kawai A; Takahashi M; Hiruma T; Matsumoto Y; Tsuchiya H; Nakayama R; Hatano H; Emori M; Hosaka M; Yoshida Y; Toguchida J; Abe S; Asanuma K; Yokoyama R; Hiraga H; Yonemoto T; Morii T; Matsumoto S; Nagano A; Yoshikawa H; Fukuda H; Ozaki T; Iwamoto Y
    World J Surg Oncol; 2018 Aug; 16(1):162. PubMed ID: 30097070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-related quality Of Life
    Younger E; Jones RL; Desar IME; Peckitt C; van der Graaf WTA; Husson O
    BMJ Open; 2020 Jun; 10(6):e035171. PubMed ID: 32487574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology.
    von Mehren M; Randall RL; Benjamin RS; Boles S; Bui MM; Ganjoo KN; George S; Gonzalez RJ; Heslin MJ; Kane JM; Keedy V; Kim E; Koon H; Mayerson J; McCarter M; McGarry SV; Meyer C; Morris ZS; O'Donnell RJ; Pappo AS; Paz IB; Petersen IA; Pfeifer JD; Riedel RF; Ruo B; Schuetze S; Tap WD; Wayne JD; Bergman MA; Scavone JL
    J Natl Compr Canc Netw; 2018 May; 16(5):536-563. PubMed ID: 29752328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Update on systemic therapy for advanced soft-tissue sarcoma.
    Smrke A; Wang Y; Simmons C
    Curr Oncol; 2020 Feb; 27(Suppl 1):25-33. PubMed ID: 32174755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
    Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
    BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Soft tissue sarcoma in Italy: From epidemiological data to clinical networking to improve patient care and outcomes.
    Trama A; Badalamenti G; Baldi GG; Brunello A; Caira M; Drove N; Marrari A; Palmerini E; Vincenzi B; Dei Tos AP; Grignani G
    Cancer Epidemiol; 2019 Apr; 59():258-264. PubMed ID: 30870746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The route to diagnosis of sarcoma patients: Results from an interview study in the Netherlands and the United Kingdom.
    Soomers VLMN; van der Graaf WTA; Zaidi S; Kaal SEJ; Hayes AJ; Schreuder BHWB; Jones RL; Desar IME; Husson O
    PLoS One; 2020; 15(12):e0243439. PubMed ID: 33284856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Soft tissue sarcoma--compliance with guidelines.
    Nijhuis PH; Schaapveld M; Otter R; Hoekstra HJ
    Cancer; 2001 Jun; 91(11):2186-95. PubMed ID: 11391601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.
    Lim HJ; Johnny Ong CA; Tan JW; Ching Teo MC
    Crit Rev Oncol Hematol; 2019 Nov; 143():1-13. PubMed ID: 31449981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors in soft tissue sarcoma.
    Maretty-Nielsen K
    Dan Med J; 2014 Nov; 61(11):B4957. PubMed ID: 25370967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Steady survival improvements in soft tissue and bone sarcoma in the Nordic countries through 50 years.
    Tichanek F; Försti A; Hemminki O; Hemminki A; Hemminki K
    Cancer Epidemiol; 2023 Sep; ():102449. PubMed ID: 37679266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histopathological diagnostic concordance in bone and soft tissue sarcomas between two comprehensive cancer centers from eastern and western Europe: a collaborative experience].
    Somcutian O; Buiga R; Galatir M; Tudor Eniu D; Rachieru C; Coza D; Terrier P
    Ann Pathol; 2015 Jan; 35(1):32-40. PubMed ID: 25541117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Soft tissue sarcomas: clinical practice guidelines].
    García Del Muro X; Martín J; Maurel J; Cubedo R; Bagué S; de Álava E; Pousa AL; Narváez JA; Ortiz E; Pomés J; Poveda A; Romasanta LP; Tendero O; Viñals JM;
    Med Clin (Barc); 2011 Apr; 136(9):408.e1-8. PubMed ID: 21411112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Real-Life Journey of Elderly Patients in Soft Tissue and Bone Sarcomas: A Retrospective Analysis from a Sarcoma Referral Center.
    Ferraresi V; Vari S; Rossi B; Maggi G; Giannarelli D; Persichetti A; Petrongari MG; Cercato MC; Annovazzi A; Anelli V; Pescarmona E; Baldi J; Zoccali C; Pellegrini D; Cognetti F; Biagini R
    J Clin Med; 2020 Aug; 9(8):. PubMed ID: 32759634
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multidisciplinary approach to soft-tissue sarcoma of the extremities.
    Nakayama R; Mori T; Okita Y; Shiraishi Y; Endo M
    Expert Rev Anticancer Ther; 2020 Oct; 20(10):893-900. PubMed ID: 32820961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.